Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alessia Filippone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy. Hauptthemen laut MEDLINE: Opuntia, Pea Proteins, Psoriasis, Dermatitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Psoriasis is a chronic inflammatory skin disease characterized by epidermal gene abnormalities, epidermal barrier defects and inflammation. Corticosteroids are considered to be standard treatments, but often come with side effects and lose efficacy with long-term use. Alternative treatments targeting the epidermal barrier defect are needed to manage the disease. Film-forming substances such as xyloglucan, pea protein and Opuntia ficus-indica extract (XPO) have generated interest for their ability to restore skin barrier integrity and may pose an alternative approach to disease management. Thus, the aim of this two-part study was to evaluate the barrier-protective properties of a topical cream containing XPO on the membrane permeability of keratinocytes exposed to inflammatory conditions and compare its efficacy to dexamethasone (DXM) in an in vivo model of psoriasis-like dermatitis. XPO treatment significantly reduced S. aureus adhesion, subsequent skin invasion and restored epithelial barrier function in keratinocytes. Furthermore, the treatment restored the integrity of keratinocytes, reducing tissue damage. In mice with psoriasis-like dermatitis, XPO significantly reduced erythema, inflammatory markers and epidermal thickening with a superior efficacy to dexamethasone. Given the promising results, XPO may represent a novel steroid-sparing therapeutic for epidermal-related diseases such as psoriasis, thanks to its ability to preserve skin barrier function and integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy.
ORCID-Profile: Alessia Filippone, Sarah Adriana Scuderi, Alessio Ardizzone, Anna Paola Capra, Salvatore Cuzzocrea, Emanuela Esposito
Zitieren
APA
Filippone, A., Casili, G., Lanza, M., Scuderi, S. A., Ardizzone, A., Capra, A. P., Paterniti, I., Campolo, M., Cuzzocrea, S., & Esposito, E. (2023). Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043122
Vancouver
Filippone A, Casili G, Lanza M, Scuderi SA, Ardizzone A, Capra AP, et al. Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043122
BibTeX
@article{Filippone2023,
author = {Filippone, Alessia and Casili, Giovanna and Lanza, Marika and Scuderi, Sarah Adriana and Ardizzone, Alessio and Capra, Anna Paola and Paterniti, Irene and Campolo, Michela and Cuzzocrea, Salvatore and Esposito, Emanuela},
title = {Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043122}
}
EUVIMED